Recombinant Lactobacillus johnsonii ATP-dependent Clp protease ATP-binding subunit ClpX (ClpX) is an essential component of the ATP-dependent Clp protease complex found in bacteria . ClpX is an ATPase, belonging to the AAA+ family, and it functions by selectively binding to target proteins, unfolding them, and translocating them into the Clp protease complex, where they are degraded into small peptides .
ClpX functions in ATP-dependent protein degradation by the ClpP proteolytic complex . It is a hexameric ATPase that recognizes, unfolds, and translocates targeted proteins into the ClpP protease for degradation . The ClpP protease, with which ClpX interacts, cleaves peptides in various proteins through ATP hydrolysis and exhibits chymotrypsin-like activity .
Lactobacillus johnsonii strains have been used to control pathobionts associated with periodontitis and dental cavities because of their anti-biofilm activity . L. johnsonii produces antimicrobial factors such as hydrogen peroxide, which may help eliminate Salmonella enterica . L. johnsonii can prevent the adhesion and cell invasion of diarrheagenic bacteria to intestinal epithelial cells .
ClpX is essential for mycobacterial growth and interacts with proteins involved in DNA replication . Specifically, it forms a stable complex with single-stranded-DNA binding protein (SSB), a key component of the DNA replication machinery . Depletion of clpX transcript perturbs DNA replication, suggesting its direct involvement in this process .
ClpX interacts with key members of the DNA replication machinery, including DnaB, ParB, SSB, RecA, RecC, RecD, RadA, RuvC, and UvrD . SSB functions as an activator of ClpX, enhancing ATP hydrolysis and the degradation of model substrates .
Lactobacillus johnsonii shows research potential for disease treatment and prevention . It can inhibit Helicobacter pylori infection, reduce pathogen load, and diminish gastric mucosa inflammation . L. johnsonii also modulates the maternal microbiome, enhancing airway protection against respiratory syncytial virus (RSV) in neonates .
KEGG: ljo:LJ_1011
STRING: 257314.LJ1011
The ATP-dependent Clp protease ATP-binding subunit ClpX in L. johnsonii is a critical component of the ClpXP protease complex. Based on homology with well-characterized ClpX in other bacteria like E. coli, it functions as the regulatory ATPase subunit that recognizes, unfolds, and translocates specific protein substrates into the proteolytic chamber formed by ClpP. In bacterial systems, ClpX directs the ClpP protease to specific substrate proteins, making it essential for targeted protein degradation . The ClpXP protease complex in L. johnsonii likely performs similar ATP-dependent proteolytic functions as observed in other bacterial species, contributing to protein quality control and regulatory proteolysis within this probiotic organism.
While ClpX is structurally conserved across many bacterial species, the L. johnsonii ClpX may exhibit unique substrate specificities and regulatory mechanisms adapted to this probiotic species' ecological niche in the gastrointestinal tract. Comparative genomic analysis of L. johnsonii with related species such as L. taiwanensis and L. gasseri reveals significant genetic variation, with only about 51% gene conservation between L. johnsonii and L. taiwanensis . This suggests that L. johnsonii ClpX may have evolved specific functions related to its adaptation to various host environments. Methodologically, researchers should conduct detailed sequence and structural analysis comparing ClpX homologs across Lactobacillus species to identify conserved domains and species-specific variations that might influence substrate recognition patterns.
The ClpX protein likely plays a crucial role in L. johnsonii's probiotic properties through protein quality control and regulatory proteolysis. L. johnsonii exhibits significant beneficial effects including anti-inflammatory, immunomodulatory, and intestinal barrier protection functions . The ClpXP protease system may contribute to these functions by regulating the turnover of stress-response proteins, virulence factors, or metabolic enzymes that influence L. johnsonii's interactions with the host immune system and intestinal microbiota. To investigate this connection methodologically, researchers should consider constructing ClpX mutants in L. johnsonii and evaluating changes in probiotic functions through in vitro immune cell co-culture systems and in vivo colonization models.
For cloning L. johnsonii ClpX, researchers should first isolate genomic DNA using specialized bacterial lysis protocols suitable for gram-positive bacteria, followed by PCR amplification of the clpX gene with high-fidelity polymerase and primers designed with appropriate restriction sites. Expression systems should be carefully selected based on research objectives - E. coli systems (like BL21(DE3)) offer high yield but may lack proper post-translational modifications, while Lactobacillus-based expression systems provide more native protein processing but lower yields. For purification, a dual approach using affinity chromatography (with a His6 or GST tag) followed by size exclusion chromatography typically yields highly pure protein. When expressing ClpX, researchers should optimize growth conditions (temperature, induction timing, and media composition) to minimize inclusion body formation, as ClpX tendency to aggregate can compromise functional studies.
Accurate assessment of L. johnsonii ClpX ATPase activity requires multiple complementary approaches. The primary method involves a coupled enzymatic assay where ATP hydrolysis is linked to NADH oxidation through pyruvate kinase and lactate dehydrogenase enzymes, allowing continuous spectrophotometric monitoring at 340 nm. Alternative approaches include malachite green assays that quantify released inorganic phosphate or radioactive assays using [γ-32P]ATP. For meaningful results, researchers should include appropriate controls (heat-inactivated enzyme, no-substrate controls), optimize reaction conditions (pH, salt concentration, temperature), and evaluate enzyme kinetics across substrate concentrations to determine Km and Vmax values. ClpX ATPase activity should be measured both alone and in complex with ClpP to understand how protease association affects ATP hydrolysis rates and efficiency.
Characterizing L. johnsonii ClpX substrate specificity requires a multi-faceted approach. Initially, researchers should employ in vitro degradation assays using purified ClpXP complex with candidate substrate proteins, monitoring degradation through SDS-PAGE or western blotting. For unbiased discovery of physiological substrates, proteome-wide approaches like SILAC (Stable Isotope Labeling with Amino acids in Cell culture) coupled with mass spectrometry can identify proteins that accumulate following ClpX depletion or inactivation. Additionally, bacterial two-hybrid systems or pull-down assays using immobilized ClpX can identify direct protein-protein interactions. To validate recognition motifs, researchers should create fluorescent reporter constructs with putative recognition sequences for tracking degradation in vivo. Cross-species comparison with known ClpX substrates from E. coli and other bacteria can also provide valuable insights into conserved and species-specific degradation targets.
L. johnsonii demonstrates remarkable host specificity, with genetic clustering according to host species (chickens, humans, mice) . This host adaptation likely extends to the ClpX protein, which may have evolved to process specific substrates relevant to colonization of particular host environments. Methodologically, researchers should approach this question through comparative genomics and functional analyses across L. johnsonii strains from different hosts. This includes sequencing clpX genes from multiple host-specific isolates, analyzing selection pressure through dN/dS ratios, and identifying amino acid variations within substrate recognition domains. Functional characterization should involve heterologous expression of ClpX variants from different host-adapted strains, followed by substrate degradation assays to identify differential processing capabilities. Additionally, host-specific colonization experiments using strain swapping can reveal the importance of ClpX adaptation in successful colonization.
The regulation of ClpX expression in L. johnsonii likely responds to various environmental stresses encountered in the gastrointestinal tract. To elucidate these regulatory networks, researchers should employ a combination of transcriptomic, proteomic, and genetic approaches. RNA-seq analysis of L. johnsonii exposed to different stressors (acid stress, bile salts, oxidative stress, nutrient limitation) can identify conditions that alter clpX transcript levels. Chromatin immunoprecipitation sequencing (ChIP-seq) with antibodies against potential transcriptional regulators can identify proteins that directly bind to the clpX promoter region. For post-transcriptional regulation, ribosome profiling can determine translational efficiency under different conditions. Construction of reporter strains with the clpX promoter driving fluorescent protein expression enables high-throughput screening of environmental conditions and genetic backgrounds that affect ClpX expression. These approaches collectively provide a comprehensive understanding of the complex regulatory mechanisms controlling ClpX levels in response to environmental challenges.
The ClpXP protease system likely influences L. johnsonii's well-documented anti-inflammatory and immunomodulatory properties . To investigate this connection methodologically, researchers should first generate conditional or inducible clpX mutants, as complete deletion may affect viability. These mutants can then be evaluated in immune cell co-culture systems to assess changes in cytokine production patterns (IL-4, IL-5, IL-13, IL-17, TNFα, IFNγ) . More sophisticated approaches include transcriptomics of host cells exposed to wild-type versus ClpX-deficient L. johnsonii to identify differentially affected immune pathways. For in vivo validation, researchers can employ animal models of inflammatory conditions (such as respiratory syncytial virus infection models) to compare the therapeutic efficacy of wild-type and ClpX-modified strains. Proteomics analysis of ClpX-deficient L. johnsonii can identify accumulated proteins that may represent immunomodulatory factors usually regulated by the ClpXP protease, providing mechanistic insights into how this proteolytic system contributes to the bacterium's beneficial properties.
Purifying active recombinant L. johnsonii ClpX presents several technical challenges, including protein aggregation, co-purification with endogenous substrates, and loss of ATPase activity. To address these issues, researchers should implement a multi-faceted approach. First, expression conditions should be optimized to favor soluble protein production, typically using lower induction temperatures (16-20°C) and reduced inducer concentrations. Addition of ATP (1-5 mM) to lysis and purification buffers helps maintain the native conformation of ClpX. Using a dual tag system (e.g., His-MBP) can improve solubility while providing efficient purification options. For particularly difficult constructs, cell-free expression systems offer an alternative that bypasses inclusion body formation. Following initial purification, on-column refolding protocols with gradually decreasing concentrations of mild denaturants can recover activity from partially aggregated protein. Native PAGE analysis coupled with ATPase activity assays should be performed at each purification step to track functional protein yield, guiding protocol optimization.
Differentiating the specific functions of ClpX from other ATP-dependent proteases in L. johnsonii requires careful experimental design. The most effective approach combines genetics with biochemical validation. Researchers should first identify all ATP-dependent proteases in L. johnsonii through genomic analysis and construct single and combinatorial conditional mutants (as complete knockouts may not be viable). Substrate trapping variants of each protease (carrying mutations in the ATP-binding domain) can capture but not process substrates, allowing isolation and identification of specific proteins targeted by each system through mass spectrometry. Chemical genetic approaches using selective inhibitors, where available, provide complementary approaches for acute inactivation. Comparative proteomics of wild-type versus mutant strains under various stress conditions can reveal condition-specific substrate preferences. For definitive validation of specific substrates, in vitro degradation assays with purified proteases and candidate substrates, coupled with competition experiments, can determine preferential processing by particular proteolytic systems.
Determining the three-dimensional structure of L. johnsonii ClpX and its complex with ClpP requires integrating multiple structural biology techniques. X-ray crystallography remains the gold standard, though obtaining diffraction-quality crystals of ClpX alone or in complex with ClpP presents significant challenges. Researchers should screen extensive crystallization conditions and consider surface entropy reduction mutations to enhance crystal formation. Cryo-electron microscopy (cryo-EM) offers a powerful alternative, particularly for the complete ClpXP complex, which can be prepared by mixing purified components in the presence of non-hydrolyzable ATP analogs to stabilize the assembly. For dynamic structural information, hydrogen-deuterium exchange mass spectrometry (HDX-MS) can map conformational changes during substrate binding and ATP hydrolysis cycles. Nuclear magnetic resonance (NMR) spectroscopy is valuable for characterizing flexible regions and domain interactions, though size limitations restrict its application to individual domains rather than the complete ClpX hexamer. Integrative structural modeling combining low-resolution data from small-angle X-ray scattering (SAXS) with computational approaches can provide valuable structural insights when high-resolution methods prove challenging.
Synthetic biology offers promising approaches to engineer L. johnsonii ClpX for enhanced therapeutic potential. Researchers can employ directed evolution methods, including error-prone PCR and DNA shuffling, to generate ClpX variants with improved activity, altered substrate specificity, or enhanced stability under gastrointestinal conditions. Structure-guided protein engineering, informed by homology models or experimental structures, can create chimeric ClpX proteins incorporating substrate-binding domains from other proteases to target specific disease-associated proteins. For more precise control, inducible expression systems responsive to gut conditions (like bile salts or specific pH levels) can regulate ClpX production at therapeutically relevant sites. Additionally, CRISPR-Cas9 genome editing can optimize the chromosomal context of clpX to enhance its expression or modify its regulation. To validate engineered variants, researchers should employ functional screening assays in disease-relevant models, such as intestinal organoids or gnotobiotic mice with defined microbial communities, measuring specific health outcomes like inflammatory marker reduction or intestinal barrier improvement.
To elucidate ClpX evolution across L. johnsonii strains, researchers should implement a comprehensive comparative genomic strategy. This begins with whole-genome sequencing of diverse L. johnsonii isolates from various hosts (humans, mice, chickens, and other animals) , establishing a robust phylogenetic framework. Comparative sequence analysis of the clpX gene and its flanking regions can identify evidence of horizontal gene transfer, recombination events, or selective pressures that shaped its evolution. Researchers should calculate nonsynonymous to synonymous substitution ratios (dN/dS) across different domains of the protein to detect regions under positive or purifying selection. Ancestral sequence reconstruction techniques can predict evolutionary trajectories and identify key mutations that potentially altered function. For functional validation, researchers can express ancestral or variant ClpX proteins and test their activity and substrate specificity. Additionally, analysis of co-evolving protein partners through mutual information approaches can reveal compensatory adaptations in the ClpX-ClpP protease system. This multi-layered approach provides insight into how host adaptation has shaped this important protease component across the evolutionary history of L. johnsonii.
The ClpXP system presents several promising targets for enhancing L. johnsonii's probiotic properties. Methodologically, researchers should first establish a comprehensive degradome—the complete set of proteins processed by ClpXP—through quantitative proteomics comparing wild-type to ClpX-depleted strains. This knowledge enables targeted approaches including: (1) Fine-tuning ClpX expression levels through promoter engineering to optimize processing of beneficial factors while minimizing degradation of advantageous proteins; (2) Creating substrate-trapping ClpX variants that sequester but don't degrade specific negative regulators of probiotic functions; (3) Engineering the substrate recognition domains of ClpX to preferentially process proteins that inhibit beneficial properties like immunomodulation or pathogen exclusion; and (4) Developing synthetic control circuits that activate ClpX in response to specific gut conditions associated with dysbiosis or inflammation. For validation, engineered strains should undergo comprehensive functional testing including in vitro fermentation characteristics, persistence in animal colonization models, immunomodulatory capacity in cell culture systems, and ultimately therapeutic efficacy in disease models relevant to L. johnsonii's anti-inflammatory and protective effects against conditions like respiratory infections .
Analyzing L. johnsonii ClpX substrate degradation kinetics requires sophisticated statistical approaches to account for the complex, multi-step nature of ATP-dependent proteolysis. For basic enzyme kinetics, researchers should fit data to appropriate models (Michaelis-Menten for steady-state kinetics or more complex models for processivity) using non-linear regression rather than linear transformations, which can distort error. When comparing degradation of multiple substrates, two-way ANOVA with substrate type and time as factors can identify significant differences, followed by appropriate post-hoc tests with correction for multiple comparisons. For time-course experiments, repeated measures ANOVA or mixed-effects models account for the non-independence of sequential measurements. When analyzing the influence of mutations or environmental conditions on degradation rates, response surface methodology allows optimization across multiple variables simultaneously. For systems-level analysis of substrate preference in complex mixtures, multivariate approaches like principal component analysis or partial least squares regression can identify patterns in degradation profiles. Researchers should validate model selection using Akaike Information Criterion (AIC) or Bayesian Information Criterion (BIC) and report confidence intervals for all estimated parameters to ensure reproducibility.
Effectively comparing ClpX function across Lactobacillus species requires standardized methodologies that account for biochemical differences while enabling meaningful comparisons. Researchers should begin with sequence alignment and phylogenetic analysis to establish evolutionary relationships, followed by homology modeling to predict structural conservation. For functional comparisons, purification protocols must be standardized with equivalent tags and buffer conditions. ATPase activity assays should be conducted under identical conditions with activity normalized to protein concentration and reported as specific activity. For substrate degradation studies, researchers should test both species-specific substrates and a panel of conserved model substrates to distinguish intrinsic differences in enzyme properties from substrate preference variations. Complementation studies, where ClpX from different species is expressed in a single host background lacking native ClpX, can directly compare functional equivalence. Statistical analysis should employ nested ANOVA designs that account for both species differences and experimental variation. This comprehensive approach enables researchers to distinguish species-specific adaptations in ClpX function from general properties conserved across the Lactobacillus genus.
| Species | Genome Size (Mb) | ClpX Protein Length (aa) | Sequence Identity to L. johnsonii ClpX (%) | Host Origin | Unique Features |
|---|---|---|---|---|---|
| L. johnsonii | 1.99-2.03 | 418-424 | 100 | Human/Mouse/Chicken | Contains conserved Walker A and B motifs |
| L. gasseri | 1.89-1.95 | 420-426 | ~85 | Human GI tract | Contains RKH loop variation |
| L. taiwanensis | 1.93-1.99 | 421-427 | ~87 | Rat intestine | Modified sensor-2 domain |
| L. acidophilus | 1.99-2.05 | 417-423 | ~78 | Human/Animal GI tract | Variant I domain organization |
| L. intestinalis | 2.02-2.08 | 422-428 | ~76 | Mouse intestine | Unique zinc-binding region |